Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Iron supplementation for restless legs syndrome - A systematic review and meta-analysis.

Avni T, Reich S, Lev N, Gafter-Gvili A.

Eur J Intern Med. 2019 May;63:34-41. doi: 10.1016/j.ejim.2019.02.009. Epub 2019 Feb 22.

PMID:
30798983
2.

Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.

Fellner A, Barhum Y, Angel A, Perets N, Steiner I, Offen D, Lev N.

Int J Mol Sci. 2017 Aug 1;18(8). pii: E1666. doi: 10.3390/ijms18081666.

3.

Seasonal Changes in the Incidence of Transient Global Amnesia.

Keret O, Lev N, Shochat T, Steiner I.

J Clin Neurol. 2016 Oct;12(4):403-406. doi: 10.3988/jcn.2016.12.4.403. Epub 2016 Apr 19.

4.

Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.

Tolmasov M, Djaldetti R, Lev N, Gilgun-Sherki Y.

Expert Rev Neurother. 2016 May;16(5):505-13. doi: 10.1586/14737175.2016.1164600. Epub 2016 Mar 25. Review.

PMID:
26959397
5.

Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.

Zarour-Shalev EH, Ovadia Y, Tuchmay O, Reynolds G, Lev N.

PDA J Pharm Sci Technol. 2015 Nov-Dec;69(6):669-76. doi: 10.5731/pdajpst.2015.01076.

PMID:
26659100
6.

A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2.

Lev N, Barhum Y, Ben-Zur T, Aharony I, Trifonov L, Regev N, Melamed E, Gruzman A, Offen D.

PLoS One. 2015 May 29;10(5):e0127549. doi: 10.1371/journal.pone.0127549. eCollection 2015.

7.

DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS.

Lev N, Barhum Y, Lotan I, Steiner I, Offen D.

PLoS One. 2015 Mar 30;10(3):e0117190. doi: 10.1371/journal.pone.0117190. eCollection 2015.

8.

Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy.

Hellmann MA, Lev N, Lotan I, Mosberg-Galili R, Inbar E, Luckman J, Fichman-Horn S, Yakimov M, Steiner I.

J Neurol Sci. 2014 Sep 15;344(1-2):193-7. doi: 10.1016/j.jns.2014.06.013. Epub 2014 Jun 17.

PMID:
25001515
9.

Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria.

Tobar A, Ori Y, Benchetrit S, Milo G, Herman-Edelstein M, Zingerman B, Lev N, Gafter U, Chagnac A.

PLoS One. 2013 Sep 25;8(9):e75547. doi: 10.1371/journal.pone.0075547. eCollection 2013.

10.

Safety of perioperative treatment with intravenous amantadine in patients with Parkinson disease.

Raz A, Lev N, Orbach-Zinger S, Djaldetti R.

Clin Neuropharmacol. 2013 Sep-Oct;36(5):166-9. doi: 10.1097/WNF.0b013e31829bd066.

PMID:
24045608
11.

Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.

Lev N, Barhum Y, Ben-Zur T, Melamed E, Steiner I, Offen D.

J Mol Neurosci. 2013 Jul;50(3):542-50. doi: 10.1007/s12031-013-9984-9. Epub 2013 Mar 28.

PMID:
23536331
12.

Mesenchymal stem cells protect from sub-chronic phencyclidine insult in vivo and counteract changes in astrocyte gene expression in vitro.

Barzilay R, Ganz J, Sadan O, Ben-Zur T, Bren Z, Hinden N, Taler M, Lev N, Gil-Ad I, Weizman A, Offen D.

Eur Neuropsychopharmacol. 2013 Sep;23(9):1115-23. doi: 10.1016/j.euroneuro.2012.10.002. Epub 2012 Oct 29.

PMID:
23116946
13.

DJ-1 protects against dopamine toxicity: implications for Parkinson's disease and aging.

Lev N, Barhum Y, Pilosof NS, Ickowicz D, Cohen HY, Melamed E, Offen D.

J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):215-25. doi: 10.1093/gerona/gls147. Epub 2012 Aug 10.

PMID:
22887838
14.

Lanthanum, constipation, bafflying X-rays and a perforated colonic diverticulum.

Korzets A, Tsitman I, Lev N, Zingerman B, Herman M, Ben Dor N, Gafter U, Ori Y.

Clin Kidney J. 2012 Aug;5(4):331-3. doi: 10.1093/ckj/sfs073. Epub 2012 Jul 6.

15.

Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS.

Fisher-Shoval Y, Barhum Y, Sadan O, Yust-Katz S, Ben-Zur T, Lev N, Benkler C, Hod M, Melamed E, Offen D.

J Mol Neurosci. 2012 Sep;48(1):176-84. doi: 10.1007/s12031-012-9805-6. Epub 2012 May 26.

PMID:
22638856
16.

Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress.

Yust-Katz S, Fisher-Shoval Y, Barhum Y, Ben-Zur T, Barzilay R, Lev N, Hod M, Melamed E, Offen D.

Cytotherapy. 2012 Jan;14(1):45-55. doi: 10.3109/14653249.2011.613928. Epub 2011 Oct 31.

PMID:
22040110
17.

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

Ganz J, Lev N, Melamed E, Offen D.

Expert Rev Neurother. 2011 Sep;11(9):1325-39. doi: 10.1586/ern.11.74. Review.

PMID:
21864078
18.

Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.

Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben-Nun A, Juknat A, Vogel Z.

Br J Pharmacol. 2011 Aug;163(7):1507-19. doi: 10.1111/j.1476-5381.2011.01379.x.

19.

Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice.

Barzilay R, Ben-Zur T, Sadan O, Bren Z, Taler M, Lev N, Tarasenko I, Uzan R, Gil-Ad I, Melamed E, Weizman A, Offen D.

Transl Psychiatry. 2011 Dec 13;1:e61. doi: 10.1038/tp.2011.64.

20.

Kinetics of interaction of HIV fusion protein (gp41) with lipid membranes studied by real-time AFM imaging.

Bitler A, Lev N, Fridmann-Sirkis Y, Blank L, Cohen SR, Shai Y.

Ultramicroscopy. 2010 May;110(6):694-700. doi: 10.1016/j.ultramic.2010.02.034. Epub 2010 Mar 16.

PMID:
20399563
21.
22.

Accelerated proteasomal activity induced by Pb2+, Ga3+, or Cu2+ exposure does not induce degradation of alpha-synuclein.

Grunberg-Etkovitz N, Lev N, Ickowicz D, Avital A, Offen D, Malik Z.

J Environ Pathol Toxicol Oncol. 2009;28(1):5-24.

PMID:
19392651
23.

Lesions outside the CNS in Parkinson's disease.

Djaldetti R, Lev N, Melamed E.

Mov Disord. 2009 Apr 30;24(6):793-800. doi: 10.1002/mds.22172. Review.

PMID:
19224610
24.

Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.

Lev N, Fridmann-Sirkis Y, Blank L, Bitler A, Epand RF, Epand RM, Shai Y.

Biochemistry. 2009 Apr 14;48(14):3166-75. doi: 10.1021/bi802243j.

PMID:
19206186
25.

DJ-1 protects against dopamine toxicity.

Lev N, Ickowicz D, Barhum Y, Lev S, Melamed E, Offen D.

J Neural Transm (Vienna). 2009 Feb;116(2):151-60. doi: 10.1007/s00702-008-0134-4. Epub 2008 Oct 31.

PMID:
18974921
26.

Toxic causes of parkinsonism.

Lev N, Melamed E, Offen D.

Handb Clin Neurol. 2007;84:385-98. doi: 10.1016/S0072-9752(07)84050-4. No abstract available.

PMID:
18808959
27.

DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS.

Lev N, Ickowicz D, Barhum Y, Melamed E, Offen D.

J Mol Neurosci. 2009 Jun;38(2):94-102. doi: 10.1007/s12031-008-9138-7. Epub 2008 Aug 19.

PMID:
18712292
28.

Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection.

Lev N, Ickowicz D, Melamed E, Offen D.

Neurotoxicology. 2008 May;29(3):397-405. doi: 10.1016/j.neuro.2008.01.007. Epub 2008 Mar 10.

PMID:
18377993
30.

Role of DJ-1 in parkinson's disease.

Lev N, Roncevich D, Ickowicz D, Melamed E, Offen D.

J Mol Neurosci. 2007 Mar;31(3):307. No abstract available.

PMID:
17726235
31.

Role of DJ-1 in Parkinson's disease.

Lev N, Roncevic D, Ickowicz D, Melamed E, Offen D.

J Mol Neurosci. 2006;29(3):215-25. Review. Erratum in: J Mol Neurosci. 2007 Mar;31(3):307. Roncevich, Dusan [corrected to Roncevic, Dusan].

PMID:
17085780
32.

Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis.

Lev N, Ickowicz D, Barhum Y, Blondheim N, Melamed E, Offen D.

Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):1987-95.

PMID:
17034344
33.

Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.

Lev N, Melamed E, Offen D.

Neurosci Lett. 2006 May 15;399(1-2):27-32. Epub 2006 Apr 11.

PMID:
16584840
34.

Effect of betamethasone administration on fetal heart rate tracing: a blinded longitudinal study.

Rotmensch S, Lev S, Kovo M, Efrat Z, Zahavi Z, Lev N, Celentano C, Ben-Rafael Z.

Fetal Diagn Ther. 2005 Sep-Oct;20(5):371-6.

PMID:
16113556
35.

Progressive multifocal leukoencephalopathy in transplant recipients.

Shitrit D, Lev N, Bar-Gil-Shitrit A, Kramer MR.

Transpl Int. 2005 Jan;17(11):658-65. Epub 2004 Dec 23. Review.

36.

Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation.

Steiner D, Avidor-Reiss T, Schallmach E, Butovsky E, Lev N, Vogel Z.

Biochem J. 2005 Mar 1;386(Pt 2):341-8.

37.

Features associated with epilepsy in the antiphospholipid syndrome.

Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, Lev N, Zaech J, Cervera R, Piette JC, Khamashta MA, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jönsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Chapman J, van-Breda-Vriezman PJ, Damoiseaux J.

J Rheumatol. 2004 Jul;31(7):1344-8.

PMID:
15229954
38.

Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.

Lev N, Barhum Y, Melamed E, Offen D.

Neurosci Lett. 2004 Apr 15;359(3):139-42.

PMID:
15050683
39.

Neuroprotection in progressive brain disorders.

Djaldetti R, Lev N, Melamed E.

Isr Med Assoc J. 2003 Aug;5(8):576-80. Review.

40.

Apoptosis and Parkinson's disease.

Lev N, Melamed E, Offen D.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):245-50. Review.

PMID:
12657363
41.

[Neurological complications in Down's Syndrome].

Lev N, Melamed E.

Harefuah. 2002 Sep;141(9):820-3, 857. Review. Hebrew.

PMID:
12362489
42.

Neurocysticercosis.

Lev N, Michowiz S, Inbar E, Coire CI, Pitlik S, Melamed E.

Isr Med Assoc J. 2002 Jan;4(1):65-6. Review. No abstract available.

43.

Spinal dural arteriovenous fistulae--a diagnostic challenge.

Lev N, Maimon S, Rappaport ZH, Melamed E.

Isr Med Assoc J. 2001 Jul;3(7):492-6.

44.

Heredity in Parkinson's disease: new findings.

Lev N, Melamed E.

Isr Med Assoc J. 2001 Jun;3(6):435-8. Review.

45.

[Spinal dural arteriovenous fistula].

Lev N, Maimon S, Melamed E, Inbar E, Rappaport Z.

Harefuah. 1999 Nov 15;137(10):471-4. Review. Hebrew. No abstract available.

PMID:
10959348
46.

[Sensory symptoms and pain in Parkinson disease].

Lev N, Melamed E.

Harefuah. 2000 Feb 15;138(4):324-6. Review. Hebrew. No abstract available.

PMID:
10883123
47.

[Evaluation of carbohydrate metabolism in children, born to mothers with diabetes mellitus, based on glucose tolerance tests].

Ignatiuk TE, Ermolenko RI, Semenova EI, Arsen'eva EN, Lev NS.

Pediatriia. 1985 Feb;(2):16-7. Russian. No abstract available.

PMID:
3991296
48.

A theoretical study of the structure of parathyroid hormone.

Zull JE, Lev NB.

Proc Natl Acad Sci U S A. 1980 Jul;77(7):3791-5.

49.

The role of informal norms in determining institutional totality in homes for the aged.

Kiyak HA, Kahana E, Lev N.

Long Term Care Health Serv Adm Q. 1979 Summer;3(2):102-10. No abstract available.

PMID:
10242246
50.

[Use of decamethoxine in otorhinolaryngology].

Rakov IM, Lev NA, Paliĭ GK.

Vestn Otorinolaringol. 1971;34(1):83-6. Russian. No abstract available.

PMID:
5154287

Supplemental Content

Support Center